Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Martin Jones

Sports Medicine Birmingham, AL Medical Doctor

NPI 1134149255 CMS profile 96304

513 Brookwood Blvd, Suite 372, Birmingham, AL 35209

Open in the dashboard

General payments

$25,007

222 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Martin Jones of Birmingham, AL is reported in the CMS Open Payments database as having received $25,007 across 222 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 73rd percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $778 25
2024 General $5,553 39
2023 General $4,233 47
2022 General $2,374 31
2021 General $3,273 30
2020 General $156 3
2019 General $8,638 47

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Martin Jones
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Martin Jones were reported at $778. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Martin Jones Sports Medicine median Middle half National median
2019 $8,638 $1,176 $199–$4,249 $163
2020 $156 $708 $96–$2,890 $114
2021 $3,273 $1,213 $152–$3,994 $132
2022 $2,374 $1,230 $159–$3,998 $149
2023 $4,233 $584 $146–$2,836 $160
2024 $5,553 $628 $163–$3,168 $164
2025 $778 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. NuVasive, Inc. $11,479 76 payments
  2. Globus Medical, Inc. $5,408 23 payments
  3. Boehringer Ingelheim International GmbH $4,755 12 payments
  4. Medtronic, Inc. $868 23 payments
  5. Boston Scientific Corporation $815 64 payments
  6. Medtronic USA, Inc. $700 8 payments
  7. Providence Medical Technology, Inc. $382 2 payments
  8. Nevro Corp. $271 5 payments
  9. Olympus America Inc. $107 1 payment
  10. Spinal Elements, Inc. $83 3 payments
  11. Other $137 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $14,166 47 payments
  2. Food and Beverage $5,462 160 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,755 12 payments
  4. Consulting Fee $600 1 payment
  5. Entertainment $16 1 payment
  6. Education $8 1 payment
Products named General payments · program years 2019–2025
  1. Traverse $4,586 8 payments
  2. GILOTRIF $3,573 10 payments
  3. ExcelsiusGPS Robotic Navigation System $3,554 3 payments
  4. XLIF $2,030 27 payments
  5. TLIF $1,641 16 payments
  6. ALIF Spine/Spine Surgery $1,108 11 payments
  7. Pulse $972 2 payments
  8. RISE-L . RISE-L A/L $804 2 payments
  9. ALIF Spine/Spine Surgery $635 3 payments
  10. MazorX Renaissance $517 4 payments
  11. Other $3,850 131 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

856

Median for Orthopedic Surgery: 203

Drug cost

$8,363

Median for Orthopedic Surgery: $1,433

Branded share of claims

29.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 193 $2,946
Cyclobenzaprine Hcl Generic 227 $1,875
Ciprofloxacin Hcl Generic 161 $1,268
Gabapentin Generic 45 $441
Methylprednisolone Generic 48 $404
Methocarbamol Generic 22 $258
Pregabalin Generic 16 $230
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 23 $223
Baclofen Generic 18 $215
Tramadol Hcl Generic 42 $205

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$130,084

Medicare's payments for the services billed

Medicare patients

249

Average age 72

Services billed

914

123 women, 126 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 37%
Ischemic heart disease 29%
Chronic kidney disease 29%
Depression 29%
COPD 21%
Osteoporosis 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

222 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record